DK0470805T3 - Oxim-carbamater og oxim-carbonater som bronchodilatatorer og antiinflammatoriske midler - Google Patents

Oxim-carbamater og oxim-carbonater som bronchodilatatorer og antiinflammatoriske midler

Info

Publication number: DK0470805T3
Authority: DK; Denmark
Prior art keywords: oxime; chem; hydrogen; independently; bronchodilators
Prior art date: 1990-08-08

Application number

DK91307197.3T

Other languages

Danish (da)

English (en)

Inventor

Louis John Lombardo

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-08

Filing date

1991-08-06

Publication date

1994-10-17

1991-08-06 Application filed by American Home Prod filed Critical American Home Prod

1994-10-17 Application granted granted Critical

1994-10-17 Publication of DK0470805T3 publication Critical patent/DK0470805T3/da

Links

-1 Oxime carbamates Chemical class 0.000 title abstract 4
229940121363 anti-inflammatory agent Drugs 0.000 title 1
239000002260 anti-inflammatory agent Substances 0.000 title 1
229940124630 bronchodilator Drugs 0.000 title 1
239000000168 bronchodilator agent Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000001769 aryl amino group Chemical group 0.000 abstract 2
125000004104 aryloxy group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
150000002431 hydrogen Chemical class 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
108010044467 Isoenzymes Proteins 0.000 abstract 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000003282 alkyl amino group Chemical group 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
230000003182 bronchodilatating effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
229940095074 cyclic amp Drugs 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
210000004969 inflammatory cell Anatomy 0.000 abstract 1
208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
150000002576 ketones Chemical class 0.000 abstract 1
150000002923 oximes Chemical class 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1
210000002460 smooth muscle Anatomy 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/62—Oximes having oxygen atoms of oxyimino groups esterified
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/60—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups having oxygen atoms of carbamate groups bound to nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Polyesters Or Polycarbonates (AREA)
Reinforced Plastic Materials (AREA)
Quinoline Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK91307197.3T 1990-08-08 1991-08-06 Oxim-carbamater og oxim-carbonater som bronchodilatatorer og antiinflammatoriske midler DK0470805T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/564,263 US5124455A (en)	1990-08-08	1990-08-08	Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents

Publications (1)

Publication Number	Publication Date
DK0470805T3 true DK0470805T3 (da)	1994-10-17

Family

ID=24253782

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91307197.3T DK0470805T3 (da)	1990-08-08	1991-08-06	Oxim-carbamater og oxim-carbonater som bronchodilatatorer og antiinflammatoriske midler

Country Status (24)

Country	Link
US (1)	US5124455A (de)
EP (1)	EP0470805B1 (de)
JP (1)	JP2651292B2 (de)
KR (1)	KR920004335A (de)
CN (1)	CN1029613C (de)
AT (1)	ATE111076T1 (de)
AU (1)	AU640251B2 (de)
CA (1)	CA2048518A1 (de)
CS (1)	CS245091A3 (de)
CY (1)	CY2057B1 (de)
DE (1)	DE69103846T2 (de)
DK (1)	DK0470805T3 (de)
ES (1)	ES2060307T3 (de)
FI (1)	FI913738A7 (de)
GB (1)	GB2246777B (de)
HU (3)	HU207289B (de)
IE (1)	IE66049B1 (de)
IL (1)	IL99081A (de)
MX (1)	MX9100549A (de)
NO (1)	NO174805B (de)
NZ (1)	NZ239279A (de)
PT (1)	PT98596B (de)
RU (1)	RU2051145C1 (de)
ZA (1)	ZA916154B (de)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5430176A (en) *	1990-07-06	1995-07-04	The Upjohn Company	Intermediate used for the preparation of deferoxamine
US5698711A (en)	1991-01-28	1997-12-16	Rhone-Poulenc Rorer Limited	Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group
GB9311281D0 (en) *	1993-06-01	1993-07-21	Rhone Poulenc Rorer Ltd	Novel composition of matter
GB9204808D0 (en) *	1992-03-04	1992-04-15	Rhone Poulenc Rorer Ltd	Novel compositions of matter
GB9212673D0 (en) *	1992-06-15	1992-07-29	Celltech Ltd	Chemical compounds
CZ14795A3 (en) *	1992-07-28	1996-07-17	Rhone Poulenc Rorer Ltd	Benzene derivative containing phenyl group bound to aryl or heteroaryl fraction through an aliphatic or hetero atom containing group, process of its preparation and pharmaceutical composition containing thereof
US5679696A (en) *	1992-07-28	1997-10-21	Rhone-Poulenc Rorer Limited	Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
GB9222253D0 (en) *	1992-10-23	1992-12-09	Celltech Ltd	Chemical compounds
US5622977A (en) *	1992-12-23	1997-04-22	Celltech Therapeutics Limited	Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9226830D0 (en) *	1992-12-23	1993-02-17	Celltech Ltd	Chemical compounds
GB9304920D0 (en) *	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
GB9304919D0 (en) *	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
GB9312853D0 (en)	1993-06-22	1993-08-04	Euro Celtique Sa	Chemical compounds
US5665754A (en) *	1993-09-20	1997-09-09	Glaxo Wellcome Inc.	Substituted pyrrolidines
US5502072A (en) *	1993-11-26	1996-03-26	Pfizer Inc.	Substituted oxindoles
GB9326173D0 (en) *	1993-12-22	1994-02-23	Celltech Ltd	Chemical compounds and process
EP0738268B1 (de) *	1993-12-22	2004-03-03	Celltech R&D Limited	Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
US5786354A (en) *	1994-06-21	1998-07-28	Celltech Therapeutics, Limited	Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en)	1994-06-21	2001-06-12	Celltech Therapeutics Limited	Tri-substituted phenyl or pyridine derivatives
GB9412571D0 (en)	1994-06-22	1994-08-10	Celltech Ltd	Chemical compounds
GB9412573D0 (en) *	1994-06-22	1994-08-10	Celltech Ltd	Chemical compounds
GB9412672D0 (en) *	1994-06-23	1994-08-10	Celltech Ltd	Chemical compounds
US5591776A (en) *	1994-06-24	1997-01-07	Euro-Celtique, S.A.	Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en)	1994-06-24	1999-07-13	Euro-Celtique, S.A.	Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6514949B1 (en)	1994-07-11	2003-02-04	University Of Virginia Patent Foundation	Method compositions for treating the inflammatory response
US6448235B1 (en)	1994-07-11	2002-09-10	University Of Virginia Patent Foundation	Method for treating restenosis with A2A adenosine receptor agonists
US5665737B1 (en) *	1994-10-12	1999-02-16	Euro Celtique Sa	Substituted benzoxazoles
US6025361A (en) *	1994-12-13	2000-02-15	Euro-Celtique, S.A.	Trisubstituted thioxanthines
DE69531506T2 (de)	1994-12-13	2004-06-24	Euroceltique S.A.	Arylthioxanthine
US6268373B1 (en)	1995-06-07	2001-07-31	Euro-Celtique S.A.	Trisubstituted thioxanthines
CA2227237C (en)	1995-07-26	2005-12-13	Pfizer Inc.	N-(aroyl)glycine hydroxamic acid derivatives and related compounds
GB9523675D0 (en) *	1995-11-20	1996-01-24	Celltech Therapeutics Ltd	Chemical compounds
GB9526245D0 (en) *	1995-12-21	1996-02-21	Celltech Therapeutics Ltd	Chemical compounds
GB9526243D0 (en) *	1995-12-21	1996-02-21	Celltech Therapeutics Ltd	Chemical compounds
GB9526246D0 (en) *	1995-12-21	1996-02-21	Celltech Therapeutics Ltd	Chemical compounds
US6075016A (en)	1996-04-10	2000-06-13	Euro-Celtique S.A.	6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9608435D0 (en) *	1996-04-24	1996-06-26	Celltech Therapeutics Ltd	Chemical compounds
US5864037A (en)	1996-06-06	1999-01-26	Euro-Celtique, S.A.	Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
JP4373497B2 (ja)	1996-06-19	2009-11-25	ローン−プーラン・ロレ・リミテツド	置換されたアザビシクロ化合物、ならびにｔｎｆおよびサイクリックａｍｐホスホジエステラーゼ産生の阻害剤としてのそれらの使用
GB9619284D0 (en) *	1996-09-16	1996-10-30	Celltech Therapeutics Ltd	Chemical compounds
US5744473A (en) *	1996-09-16	1998-04-28	Euro-Celtique, S.A.	PDE IV inhibitors: "bis-compounds"
GB9622363D0 (en)	1996-10-28	1997-01-08	Celltech Therapeutics Ltd	Chemical compounds
GB9625184D0 (en) *	1996-12-04	1997-01-22	Celltech Therapeutics Ltd	Chemical compounds
EP0946523A1 (de)	1996-12-23	1999-10-06	Celltech Therapeutics Limited	Kondensierte polycyclische 2-aminopyrimidinderivate, ihre herstellung und verwendung als proteininhibitoren von tyrosinkinase
US5981549A (en) *	1997-02-14	1999-11-09	Synapse Pharmaceutical International	Method for controlling or alleviating the symptoms of respiratory disease and allergies
GB9705361D0 (en)	1997-03-14	1997-04-30	Celltech Therapeutics Ltd	Chemical compounds
GB9713087D0 (en) *	1997-06-20	1997-08-27	Celltech Therapeutics Ltd	Chemical compounds
CN1130363C (zh)	1997-11-12	2003-12-10	三菱化学株式会社	嘌呤衍生物以及含有其作为有效成分的药物
US6117878A (en) *	1998-02-24	2000-09-12	University Of Virginia	8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
KR100479019B1 (ko) *	1998-05-22	2005-08-29	씨제이 주식회사	캐테콜히드라존유도체,이의제조방법및그를함유한약제학적조성물
KR100578425B1 (ko) *	1998-10-16	2007-01-11	씨제이 주식회사	캐테콜 히드라진 유도체, 이의 제조 방법 및 이를 함유한 약제학적 조성물
US6232297B1 (en)	1999-02-01	2001-05-15	University Of Virginia Patent Foundation	Methods and compositions for treating inflammatory response
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
WO2000068231A1 (en) *	1999-05-11	2000-11-16	Mitsubishi Chemical Corporation	Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
GB9914258D0 (en)	1999-06-18	1999-08-18	Celltech Therapeutics Ltd	Chemical compounds
US6322771B1 (en)	1999-06-18	2001-11-27	University Of Virginia Patent Foundation	Induction of pharmacological stress with adenosine receptor agonists
CA2715683A1 (en)	1999-08-21	2001-03-01	Nycomed Gmbh	Synergistic combination
GB9924862D0 (en)	1999-10-20	1999-12-22	Celltech Therapeutics Ltd	Chemical compounds
CA2402384A1 (en) *	2000-03-16	2001-09-20	Inflazyme Pharmaceuticals Ltd.	Benzylated pde4 inhibitors
BR0209774A (pt) *	2001-05-29	2004-06-01	Schering Ag	Pirimidinas inibidoras de cdk, sua preparação e aplicação como medicamento
AU2002322720B2 (en)	2001-07-25	2008-11-13	Raptor Pharmaceutical Inc.	Compositions and methods for modulating blood-brain barrier transport
NZ556354A (en) *	2001-10-01	2008-10-31	Univ Virginia	2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
US7153824B2 (en)	2003-04-01	2006-12-26	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
FR2861069B1 (fr) *	2003-10-17	2005-12-09	Galderma Res & Dev	NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
US7122705B2 (en) *	2004-04-08	2006-10-17	Wyeth	Method for preparing 3-cyclopentyloxy-4-methoxybenzaldehyde
ATE413398T1 (de) *	2004-04-08	2008-11-15	Wyeth Corp	Thioamidderivate als progesteronrezeptormodulatoren
US7576069B2 (en) *	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006023272A1 (en) *	2004-08-02	2006-03-02	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having a2a agonist activity
AU2005267706B2 (en) *	2004-08-02	2011-12-08	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
CA2789262C (en)	2005-04-28	2016-10-04	Proteus Digital Health, Inc.	Pharma-informatics system
JP2009514969A (ja)	2005-11-09	2009-04-09	コンビナトアールエックスインコーポレーティッド	医学的状態を治療するための方法、組成物、およびキット
US8178509B2 (en) *	2006-02-10	2012-05-15	University Of Virginia Patent Foundation	Method to treat sickle cell disease
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
EP2063905B1 (de)	2006-09-18	2014-07-30	Raptor Pharmaceutical Inc	Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
MX354786B (es)	2007-06-04	2018-03-21	Synergy Pharmaceuticals Inc	Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2022783A1 (de)	2007-08-08	2009-02-11	CHIESI FARMACEUTICI S.p.A.	1-Phenyl-2-Pyridinylalkyl-Alkoholderivate als Phosphodiesterasehemmer
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
ES2522968T3 (es)	2008-06-04	2014-11-19	Synergy Pharmaceuticals Inc.	Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en)	2008-07-16	2015-02-19	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
TR201908314T4 (tr)	2009-02-20	2019-06-21	2 Bbb Medicines B V	Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko)	2009-05-06	2018-12-19	라보라토리 스킨 케어, 인크.	활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates
DK2681236T3 (en)	2011-03-01	2018-04-16	Synergy Pharmaceuticals Inc	PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
WO2014131024A2 (en)	2013-02-25	2014-08-28	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
BR112015030326A2 (pt)	2013-06-05	2017-08-29	Synergy Pharmaceuticals Inc	Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en)	2013-08-09	2019-08-29	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
CN106146350B (zh) *	2016-07-21	2017-10-20	华南理工大学	一种合成氨基甲酸肟酯衍生物的新方法
EP4706758A3 (de)	2019-05-21	2026-05-06	Ardelyx, Inc.	Verfahren zur hemmung des phosphattransports

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3466316A (en) *	1964-09-23	1969-09-09	Union Carbide Corp	Alpha-cyano carbamoyloxime compounds
FR1575544A (de) *	1967-11-09	1969-07-25
US3923833A (en) *	1968-05-01	1975-12-02	Hoffmann La Roche	N-{8 (1-cyano-2-phenyl)ethyl{9 carbamates
US3647861A (en) *	1970-08-25	1972-03-07	Du Pont	Substituted o-carbamylhydroxamates
DE2111156C3 (de) *	1971-03-09	1975-11-06	Hoechst Ag, 6000 Frankfurt	Oximcarbamatverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende insektizide Mittel
FR2201885A1 (en) *	1972-10-10	1974-05-03	Delalande Sa	4-Aryl carbonyl methyl pyrimidine oxime carbamates - prepd. by treatment of the oxime with an isocyanate, used as sedatives, analgesics, vasodilators, diuretics
FR2202689B1 (de) *	1972-10-17	1975-10-31	Delalande Sa
FR2204406A1 (en) *	1972-10-26	1974-05-24	Delalande Sa	1-Phenyl-3-aminocarbonylpropan-1-one oxime carbamates - with analgesic, antiinflammatory, hypotensive and sedative activities etc.
FR2244499A1 (en) *	1973-06-07	1975-04-18	Delalande Sa	Indol-3-ylformaldoxime carbamates - for treating anxiety epilepsy, cardiac arrhythmias, asthma, intestinal spasm, peptic ulcer, cardiac insufficiency
DE2655369A1 (de) *	1976-12-03	1978-06-08	Schering Ag	5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
HU179019B (en) *	1978-11-01	1982-08-28	Gyogyszekutato Intezet	Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
US4475945A (en) *	1980-01-14	1984-10-09	Ciba-Geigy Corporation	Aminoglyoxyloitrile oximino carboxylic acid esters and thio esters for the protection of crops against injury by herbicides
DE3438839A1 (de) *	1984-10-19	1986-04-24	Schering AG, 1000 Berlin und 4709 Bergkamen	Pharmazeutische praeparate
EP0186817B1 (de) *	1984-12-10	1989-08-02	Nissan Chemical Industries Ltd.	3(2H)Pyridazinon, Verfahren zu seiner Herstellung und dieses enthaltendes anti-allergisches Mittel
FI875724A0 (fi) *	1986-04-29	1987-12-28	Pfizer	Av kalcium oberoende camp fosfodiesteras-inhibitordepressant.
GB8711802D0 (en) *	1987-05-19	1987-06-24	Fujisawa Pharmaceutical Co	Dithioacetal compounds
RU2104306C1 (ru) *	1989-11-13	1998-02-10	Пфайзер Инк.	Способ получения оптически активного (2s)- или (2r)-эндо-бицикло[2.2.1]гептан-2-ола, способ получения 5-(3-[(2r)-экзо-бицикло[2.2.1]гепт-2-илокси]-4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-она, оптически активный 5-(3-[экзо-бицикло[2.2.1]гепт-2-илокси]4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-он, оптически активные промежуточные соединения и способ их получения

1990
- 1990-08-08 US US07/564,263 patent/US5124455A/en not_active Expired - Fee Related
1991
- 1991-08-05 JP JP3195183A patent/JP2651292B2/ja not_active Expired - Lifetime
- 1991-08-05 ZA ZA916154A patent/ZA916154B/xx unknown
- 1991-08-05 IL IL9908191A patent/IL99081A/en unknown
- 1991-08-05 AU AU81623/91A patent/AU640251B2/en not_active Ceased
- 1991-08-06 FI FI913738A patent/FI913738A7/fi unknown
- 1991-08-06 KR KR1019910013552A patent/KR920004335A/ko not_active Abandoned
- 1991-08-06 DK DK91307197.3T patent/DK0470805T3/da active
- 1991-08-06 NZ NZ239279A patent/NZ239279A/xx unknown
- 1991-08-06 DE DE69103846T patent/DE69103846T2/de not_active Expired - Fee Related
- 1991-08-06 MX MX9100549A patent/MX9100549A/es unknown
- 1991-08-06 GB GB9116950A patent/GB2246777B/en not_active Expired - Fee Related
- 1991-08-06 ES ES91307197T patent/ES2060307T3/es not_active Expired - Lifetime
- 1991-08-06 AT AT91307197T patent/ATE111076T1/de active
- 1991-08-06 EP EP91307197A patent/EP0470805B1/de not_active Expired - Lifetime
- 1991-08-07 HU HU912634A patent/HU207289B/hu not_active IP Right Cessation
- 1991-08-07 HU HU9202417A patent/HU215159B/hu not_active IP Right Cessation
- 1991-08-07 RU SU915001278A patent/RU2051145C1/ru active
- 1991-08-07 NO NO913065A patent/NO174805B/no unknown
- 1991-08-07 IE IE279491A patent/IE66049B1/en not_active IP Right Cessation
- 1991-08-07 CA CA002048518A patent/CA2048518A1/en not_active Abandoned
- 1991-08-07 CN CN91105530A patent/CN1029613C/zh not_active Expired - Fee Related
- 1991-08-07 PT PT98596A patent/PT98596B/pt not_active IP Right Cessation
- 1991-08-07 CS CS912450A patent/CS245091A3/cs unknown
1995
- 1995-06-28 HU HU95P/P00483P patent/HU211643A9/hu unknown
1998
- 1998-04-30 CY CY9802057A patent/CY2057B1/xx unknown

Also Published As

Publication number	Publication date
MX9100549A (es)	1992-04-01
ES2060307T3 (es)	1994-11-16
NO174805C (de)	1994-07-13
ZA916154B (en)	1993-04-28
JPH04253945A (ja)	1992-09-09
CY2057B1 (en)	1998-04-30
HUT61273A (en)	1992-12-28
DE69103846D1 (de)	1994-10-13
KR920004335A (ko)	1992-03-27
HU211643A9 (en)	1995-12-28
HU912634D0 (en)	1992-01-28
FI913738A0 (fi)	1991-08-06
AU640251B2 (en)	1993-08-19
GB2246777A (en)	1992-02-12
IE912794A1 (en)	1992-02-12
HK1000103A1 (en)	1997-11-28
ATE111076T1 (de)	1994-09-15
EP0470805A1 (de)	1992-02-12
US5124455A (en)	1992-06-23
JP2651292B2 (ja)	1997-09-10
FI913738A7 (fi)	1992-02-09
CN1029613C (zh)	1995-08-30
NZ239279A (en)	1993-09-27
HUT58694A (en)	1992-03-30
RU2051145C1 (ru)	1995-12-27
NO913065D0 (no)	1991-08-07
GB2246777B (en)	1994-08-17
GB9116950D0 (en)	1991-09-18
NO913065L (no)	1992-02-10
PT98596B (pt)	1999-03-31
NO174805B (no)	1994-04-05
IL99081A0 (en)	1992-07-15
IE66049B1 (en)	1995-12-13
DE69103846T2 (de)	1995-01-12
IL99081A (en)	1995-05-26
CA2048518A1 (en)	1992-02-09
PT98596A (pt)	1992-07-31
CS245091A3 (en)	1992-03-18
HU215159B (hu)	1998-12-28
HU207289B (en)	1993-03-29
AU8162391A (en)	1992-02-13
CN1058771A (zh)	1992-02-19
EP0470805B1 (de)	1994-09-07

Publication	Publication Date	Title
DK0470805T3 (da)	1994-10-17	Oxim-carbamater og oxim-carbonater som bronchodilatatorer og antiinflammatoriske midler
DE69217112D1 (de)	1997-03-13	Phenyl-pyrazolidinone als Bronchodilatatoren und entzündungshemmende Mittel
GR3035526T3 (en)	2001-06-29	Retroviral protease inhibitors.
DK1473294T3 (da)	2007-09-17	Substituerede1,3-oxathiolaner med antivirale egenskaber
ATE112558T1 (de)	1994-10-15	Glycosidasehemmer.
NO943631D0 (no)	1994-09-29	Substituerte fenylkarbamater og urinstoffer
DK617284D0 (da)	1984-12-20	Naphthalenderivater
DK544689D0 (da)	1989-11-01	Terapeutisk aktive forbindelser
NO931225D0 (no)	1993-03-31	Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet
PT82550A (en)	1986-06-01	1,3 oxathiane derivatives
ES8800255A1 (es)	1987-11-01	Procedimiento para preparar n6 -benzopirano- y benzotiopirano-adenosinas.
EP0079049A3 (en)	1983-06-22	Novel substituted alkanoylimidazol-2-one derivatives
IE890977L (en)	1989-09-24	Isoxazolinones
NO910965D0 (no)	1991-03-12	Aminderivater med fungicid aktivitet.
TH33845A (de)	1999-07-16